7R4Q
The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
Summary for 7R4Q
Entry DOI | 10.2210/pdb7r4q/pdb |
EMDB information | 14314 |
Descriptor | Spike glycoprotein, Camel-derived nanobody 1.29, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total) |
Functional Keywords | coronavirus, covid-19, sars-cov-2, spike, nanobodies, neutralization, viral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 More |
Total number of polymer chains | 5 |
Total formula weight | 456460.75 |
Authors | Casasnovas, J.M.,Melero, R.,Arranz, R.,Fernandez, L.A. (deposition date: 2022-02-09, release date: 2022-06-08) |
Primary citation | Casasnovas, J.M.,Margolles, Y.,Noriega, M.A.,Guzman, M.,Arranz, R.,Melero, R.,Casanova, M.,Corbera, J.A.,Jimenez-de-Oya, N.,Gastaminza, P.,Garaigorta, U.,Saiz, J.C.,Martin-Acebes, M.A.,Fernandez, L.A. Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron. Front Immunol, 13:863831-863831, 2022 Cited by PubMed: 35547740DOI: 10.3389/fimmu.2022.863831 PDB entries with the same primary citation |
Experimental method | ELECTRON MICROSCOPY (3.6 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)